StockData
Vistagen Therapeutics, Inc. logo

Vistagen Therapeutics, Inc. (VTGN) stock

VTGNNasdaqPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 9/3078% below fair value
$0.20+0.01 (+6.12%)

Close on Nov 18, 2026Market cap $8.85MP/E –Yield –

Vistagen Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Vistagen Therapeutics's total debt was $87.30K at Sep 30, 2020. For fiscal 2020 it was $0. The highest annual figure on record is $1.44M in fiscal 2014.

Annual total debt

PeriodPeriod endValueChange
FY2020Mar 31, 2020$0–
FY2018Mar 31, 2018$0–
FY2017Mar 31, 2017$0-100.0%
FY2016Mar 31, 2016$27.20K-23.6%
FY2015Mar 31, 2015$35.60K-97.5%
FY2014Mar 31, 2014$1.44M–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2021CQ3 2020Sep 30, 2020$87.30K–
Q1 FY2021CQ2 2020Jun 30, 2020$124.70K–
Q4 FY2020CQ1 2020Mar 31, 2020$0–
Q4 FY2018CQ1 2018Mar 31, 2018$0–
Q4 FY2017CQ1 2017Mar 31, 2017$0–
Q3 FY2017CQ4 2016Dec 31, 2016$0–
Q2 FY2017CQ3 2016Sep 30, 2016$0–

More Vistagen Therapeutics figures

See a number that looks wrong?